Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorShteinberg, Michal
dc.contributor.authorBoyd, Jeanette
dc.contributor.authorAliberti, Stefano
dc.contributor.authorPolverino, Eva
dc.contributor.authorHarris, Bridget
dc.contributor.authorBerg, Tove
dc.date.accessioned2022-03-14T13:22:51Z
dc.date.available2022-03-14T13:22:51Z
dc.date.issued2021-02-15
dc.identifier.citationShteinberg M, Boyd J, Aliberti S, Polverino E, Harris B, Berg T, et al. What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Res. 2021 Feb 15;7:00807–2020.
dc.identifier.issn2312-0541
dc.identifier.urihttp://hdl.handle.net/11351/7167
dc.descriptionPatient experiences; Lung disease
dc.description.abstractPatients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff
dc.language.isoeng
dc.publisherEuropean Respiratory Society
dc.relation.ispartofseriesERJ Open Research;7
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectMicobacteriosis - Tractament
dc.subjectEnquestes
dc.subjectPacients - Satisfacció
dc.subject.meshMycobacterium Infections, Nontuberculous
dc.subject.mesh/therapy
dc.subject.meshSurveys and Questionnaires
dc.titleWhat is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1183/23120541.00807-2020
dc.subject.decsinfecciones por micobacterias no tuberculosas
dc.subject.decs/terapia
dc.subject.decsencuestas y cuestionarios
dc.relation.publishversionhttps://doi.org/1183/23120541.00807-2020
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Shteinberg M] Pulmonology Institute and CF Center, Carmel Medical Center and the Technion, Israel Institute of Technology, Haifa, Israel. [Boyd J] European Lung Foundation, Sheffield, UK. [Aliberti S] Dept of Pathophysiology and Transplantation, University of Milan, and Internal Medicine Dept, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy. [Polverino E] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Thorax Institute, Institute of Biomedical Research August Pi i Sunyer, University of Barcelona, Barcelona, Spain. [Harris B, Berg T] European Lung Foundation Bronchiectasis Patient Advisory Group, Edinburgh, UK
dc.identifier.pmid33614773
dc.identifier.wos000625441800065
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record